Literature DB >> 28899662

Baseline Association of Motoric Cognitive Risk Syndrome With Sustained Attention, Memory, and Global Cognition.

Fiachra J Maguire1, Isabelle Killane2, Andrew P Creagh3, Orna Donoghue4, Rose Anne Kenny5, Richard B Reilly6.   

Abstract

OBJECTIVES: Slow gait has been shown to be a good predictor of declining cognitive function in healthy older adults. Motoric cognitive risk (MCR) syndrome is a new construct incorporating slow gait and subjective cognitive complaints in individuals without dementia who have preserved activities of daily living. This analysis investigated the prevalence of MCR and factors associated with MCR in a nationally representative population. In addition, cross-sectional associations between MCR and cognitive domains, an relationship yet to be fully elucidated in literature, was investigated. MEASUREMENTS: Participants completed a comprehensive neuropsychological assessment and gait analysis at a health assessment center. Logistic regression was employed to examine associated health factors. Composite scores reflecting global cognition, memory, sustained attention, executive function, and processing speed were constructed using neuropsychological test scores. Associations between MCR and these composites were quantified using multivariate generalized linear modelling. All analyses were weighted to be nationally representative.
SETTING: Community-dwelling adults in The Irish Longitudinal Study on Aging (TILDA) completed an interview and a center-based health assessment. PARTICIPANTS: Participants aged 60 years and over (n = 2151, age; mean: 67.84 years, range: 60-93) were included. Participants with a Mini-Mental State Examination score of below 24, a diagnosis of serious memory impairment, Parkinson disease, dementia, or Alzheimer disease were excluded.
RESULTS: MCR prevalence was estimated at 2.56% (95% confidence interval 1.97, 3.31). Significant risk factors for MCR were antidepressant use [odds ratio (OR) 4.46, P < .001], self-reported poor vision (OR 4.92, P < .05), and obesity (OR 2.29, P < .01). Individuals with MCR performed worse on tests that assess memory (B: -0.58, P < .001), global cognition (B: -0.42, P < .001), and sustained attention (B: -0.34, P < .05) with robust adjustment made for confounding demographic and health variables.
CONCLUSIONS: MCR is characterized by strong negative associations with global cognition, attention, and memory. This may be indicative of the underlying pathology of MCR. The effect of antidepressant use on MCR is novel and may represent an important consideration in future studies.
Copyright © 2017 AMDA – The Society for Post-Acute and Long-Term Care Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Gait; cognitive function; dementia

Mesh:

Year:  2017        PMID: 28899662     DOI: 10.1016/j.jamda.2017.07.016

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  11 in total

1.  The association of anxio-depressive disorders and depression with motoric cognitive risk syndrome: results from the baseline assessment of the Canadian longitudinal study on aging.

Authors:  Harmehr Sekhon; Gilles Allali; Olivier Beauchet
Journal:  Geroscience       Date:  2019-08-28       Impact factor: 7.713

2.  Non-memory subjective cognitive concerns predict incident motoric cognitive risk syndrome.

Authors:  C Nester; E Ayers; L Rabin; J Verghese
Journal:  Eur J Neurol       Date:  2020-05-19       Impact factor: 6.089

Review 3.  Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults.

Authors:  Richard D Semba; Qu Tian; Michelle C Carlson; Qian-Li Xue; Luigi Ferrucci
Journal:  Ageing Res Rev       Date:  2020-01-26       Impact factor: 10.895

4.  Cognitive Motor Dual Task Costs in Older Adults with Motoric Cognitive Risk Syndrome.

Authors:  N Ward; A Menta; S Peach; S A White; S Jaffe; C Kowaleski; K Grandjean da Costa; J Verghese; K F Reid
Journal:  J Frailty Aging       Date:  2021

5.  Motoric Cognitive Risk Syndrome in Polypharmacy.

Authors:  Claudene J George; Joe Verghese
Journal:  J Am Geriatr Soc       Date:  2020-02-24       Impact factor: 5.562

6.  Personality and Motoric Cognitive Risk Syndrome.

Authors:  Yannick Stephan; Angelina R Sutin; Brice Canada; Antonio Terracciano
Journal:  J Am Geriatr Soc       Date:  2019-12-27       Impact factor: 5.562

7.  The Association Between Subjective Age and Motoric Cognitive Risk Syndrome: Results From a Population-Based Cohort Study.

Authors:  Yannick Stephan; Angelina R Sutin; Brice Canada; Antonio Terracciano
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2021-11-15       Impact factor: 4.077

8.  Risk factors for the progression of motoric cognitive risk syndrome to dementia: Retrospective cohort analysis of two populations.

Authors:  Zeev Meiner; Emmeline Ayers; David A Bennett; Cuiling Wang; Joe Verghese
Journal:  Eur J Neurol       Date:  2021-04-14       Impact factor: 6.288

Review 9.  Compromised prefrontal structure and function are associated with slower walking in older adults.

Authors:  Victoria N Poole; Thomas Wooten; Ikechukwu Iloputaife; William Milberg; Michael Esterman; Lewis A Lipsitz
Journal:  Neuroimage Clin       Date:  2018-08-10       Impact factor: 4.881

Review 10.  Motoric Cognitive Risk Syndrome: Symptoms, Pathology, Diagnosis, and Recovery.

Authors:  Ke Xiang; Yin Liu; Li Sun
Journal:  Front Aging Neurosci       Date:  2022-02-02       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.